GNH USA

Europe — EMA

Morphine Kalceks (Morphine Hydrochloride Trihydrate)

GNH USA supplies Morphine Kalceks (Morphine Hydrochloride Trihydrate), an opioid analgesic for severe acute, post‑operative and cancer‑related pain.

Request sourcing

1
Pack/s

What is Morphine Hydrochloride Trihydrate?

Morphine Hydrochloride Trihydrate, the active ingredient in Morphine Kalceks, is an opioid analgesic presented as a sterile injectable solution for intramuscular, intravenous, or subcutaneous use. It provides potent analgesia for severe acute, post‑operative, and cancer‑related pain in adult patients requiring strong opioid therapy. It is commonly employed in hospital settings for rapid pain control.

GNH USA supplies Morphine Kalceks as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for cross‑border distribution.

What is Morphine Hydrochloride Trihydrate used for?

Morphine acts on the µ‑opioid receptor pathway to relieve pain in several clinical contexts.

- Severe acute pain: provides rapid, strong analgesia for sudden, intense pain episodes. - Post‑operative pain: reduces pain intensity after surgical procedures, facilitating recovery. - Cancer‑related pain: manages persistent pain associated with malignant disease and its treatment.

What are the side effects of Morphine Hydrochloride Trihydrate?

Morphine may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Nausea - Constipation - Drowsiness - Dizziness

Serious or Rare Side Effects: - Respiratory depression - Severe hypotension - Anaphylactic reaction

What precautions apply to Morphine Hydrochloride Trihydrate?

When prescribing Morphine, clinicians should observe several safety considerations to minimize risks.

- Dose titration: adjust based on analgesic response and tolerance. - Respiratory monitoring: observe for depression especially in opioid‑naïve patients. - Concurrent CNS depressants: avoid or use with caution. - Renal/hepatic impairment: consider dose reduction. - Addiction potential: assess risk and monitor for misuse. - Store below 25°C: keep in original container, protect from light and moisture.

What does Morphine Hydrochloride Trihydrate interact with?

Morphine can interact with other medicines, altering its effect or increasing adverse events.

Major Interactions (Avoid): - Concurrent use of other respiratory depressants (e.g., benzodiazepines). - Monoamine oxidase inhibitors (MAOIs) within 14 days. - Alcohol or other CNS depressants.

Moderate Interactions (Monitor Closely): - Strong CYP3A4 inhibitors (e.g., erythromycin, ketoconazole). - CYP3A4 inducers (e.g., rifampin, carbamazepine). - Diuretics that may enhance hypotensive effects.

Frequently asked questions

What is Morphine Kalceks used for?+
Morphine Kalceks is an injectable opioid analgesic used to manage severe acute pain, post‑operative pain, and cancer‑related pain when a strong, rapid‑acting opioid is required. It is typically administered in hospital, surgical, or palliative‑care settings under professional supervision.
How does morphine work?+
Morphine works by binding to µ‑opioid receptors in the brain, spinal cord and peripheral nervous system. This activation inhibits the release of excitatory neurotransmitters, reduces neuronal firing, and blocks the transmission of pain signals, producing analgesia and a degree of sedation.
What is the usual dose of Morphine Kalceks?+
The dose of Morphine Kalceks is individualized. A qualified prescriber determines the appropriate amount, route, and frequency based on the patient’s pain severity, prior opioid exposure, age, organ function and other clinical factors. No standard dosing information is provided here.
Is Morphine Kalceks safe in pregnancy or breastfeeding?+
Data on the safety of morphine during pregnancy and lactation are limited. Because opioids can cross the placenta and enter breast milk, use is generally avoided unless the benefit outweighs potential risk. Clinicians should evaluate each case carefully.
How do I order Morphine Kalceks from GNH USA?+
To order, submit an enquiry on the product page at gnh-usa.com specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.
How does Morphine Kalceks compare with other opioid options?+
Morphine is a benchmark opioid with a well‑characterized efficacy and safety profile. Compared with synthetic opioids such as fentanyl, morphine has a longer onset but a shorter duration of action, making it suitable for titration in acute settings. Choice depends on pain type, required speed of relief, and patient‑specific factors.
What are the storage and handling requirements for Morphine Kalceks?+
Morphine Kalceks should be stored below 25 °C in its original packaging, protected from light and moisture. Do not freeze the product. Inspect the solution for particulate matter or discoloration before use, and discard any vial that appears compromised.
How is Morphine Kalceks administered?+
The product is supplied as a sterile injectable solution and may be given by intramuscular, intravenous, or subcutaneous injection. Administration technique follows standard aseptic procedures, and dosing is adjusted by the prescriber according to the clinical situation and patient response.
What are the most serious risks associated with Morphine Kalceks?+
The most critical risks include respiratory depression, severe hypotension, and the potential for addiction or dependence. Anaphylactic reactions and profound sedation can also occur. Prompt monitoring of respiratory function and vigilance for signs of misuse are essential during therapy.
Who should not use Morphine Kalceks?+
Morphine Kalceks is contraindicated in patients with known hypersensitivity to morphine or any component of the formulation, those with severe respiratory depression, acute or severe asthma, and in individuals who have taken MAO inhibitors within the past 14 days. Caution is also advised in patients with significant renal or hepatic impairment.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Morphine Hydrochloride Trihydrate
Route
Intramuscular Use , Intravenous Use , Subcutaneous
Manufacturer
Kalceks
Origin
EU

Related products